Author: Gandolfini, Ilaria; Zanelli, Paola; Palmisano, Alessandra; Salvetti, Daniel; Parmigiani, Alice; Maltzman, Jonathan S.; Labate, Claudia; Fiaccadori, Enrico; Cravedi, Paolo; Maggiore, Umberto
Title: Antiâ€HLA and antiâ€SARSâ€CoVâ€2 antibodies in kidney transplant recipients with COVIDâ€19 Cord-id: an1wfsvk Document date: 2021_2_26
ID: an1wfsvk
Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its associated illness coronavirus disease 2019 (COVID-19) have severely affected organ transplant recipients, with all-cause mortality rates exceeding 20% (1, 2). Although no clear guidelines exist on how to adjust immunosuppression, most centers reduce anti-rejection drugs to facilitate the T and B cell response against the virus.
Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its associated illness coronavirus disease 2019 (COVID-19) have severely affected organ transplant recipients, with all-cause mortality rates exceeding 20% (1, 2). Although no clear guidelines exist on how to adjust immunosuppression, most centers reduce anti-rejection drugs to facilitate the T and B cell response against the virus.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date